Status:
COMPLETED
Association Between the Composition of the Bacterial Flora of Thrombi and the Etiological Origin of Cerebral Infarction Treated With Thrombectomy
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Patient With Symptomatic Cerebral Infarction
Patient Who Has Had a Mechanical Thrombectomy
Eligibility:
All Genders
18+ years
Brief Summary
Cerebral infarction is a major health problem. The two most common causes are atherosclerosis (30 to 35%) and cardio-embolic origin (35 to 40%). However, in 25% of cases the cause is undetermined, kno...
Eligibility Criteria
Inclusion
- Person who has given oral consent (or a close relative or legal representative if the patient is unable to give consent)
- Patient with a symptomatic cerebral infarction defined according to WHO criteria, who has had a mechanical thrombectomy and was hospitalized at the Neurovascular Intensive Care Unit of the Dijon University Hospital.
- 18 years or older
Exclusion
- Person not affiliated to national health insurance
- Person under legal protection (curatorship, guardianship)
- Person under court order
- Pregnant or breastfeeding
- Patient who refuses to participate in the study
- Patient (or family member) not reachable by telephone during follow-up.
Key Trial Info
Start Date :
February 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03825679
Start Date
February 11 2019
End Date
January 4 2020
Last Update
November 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire
Dijon, France, 21079